Sponsor or institution
Clinical trials and research at Institute of Oncology Ljubljana
As of November 12, 2026, Find a Trial lists 17 clinical trials run by Institute of Oncology Ljubljana that are recruiting, in Slovenia. By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 17Clinical trials
- 1Country
Newest trials
All recruiting trials (17)
-
Genetic assessment of breast cancer risk for women in the DORA programme
This study tests whether a detailed clinical and genetic review can better classify breast cancer risk for women previously identified as moderately increased or high risk.
-
Resting energy tests in people with normal digestion vs. intestinal failure
This study tests resting energy expenditure in adults with and without intestinal failure to help tailor nutrition needs.
-
Bleomycin Electrosclerotherapy for Low-Flow Vascular Malformations
This trial tests whether adding electrical pulses to bleomycin injections (BEST) can better treat low-flow vascular malformations in adults.
-
Prophylactic Radiotherapy to Prevent Bone Complications in Metastatic Cancers
This study tests whether giving early radiotherapy to high-risk bone metastases, in addition to standard care, can reduce bone-related problems in adults with metastatic solid cancers.
-
Cognitive changes in people treated for diffuse large B‑cell lymphoma
This study tests whether adults with newly diagnosed diffuse large B‑cell lymphoma experience cognitive changes during and after standard chemotherapy.
-
Focused high-dose SBRT for spinal tumors
This program will try focused high-dose SBRT for adults with spinal metastases to track side effects and local tumor control during routine care.
-
Quality of life after colorectal cancer treatment
This project will test whether late side effects at 6, 12, and 24 months affect quality of life in people aged 25–65 who completed initial treatment for colorectal cancer at the Institute of Oncology Ljubljana.
-
Anabolic response to IV amino acids in people with chronic intestinal failure
This will test whether giving IV amino acids helps people with chronic intestinal failure on home parenteral nutrition build and maintain body protein and better match their individual protein needs.
-
First-line immunotherapy and PD-L1 testing for metastatic melanoma in Slovenia
This study will see if first-line immunotherapy (pembrolizumab, nivolumab, or ipilimumab plus nivolumab) works for adults in Slovenia with metastatic melanoma and whether PD-L1 measurements predict who responds.
-
Circulating tumor cell clusters and ctDNA in high-risk early breast cancer
This project will test whether a blood test measuring circulating tumor cell clusters and circulating tumor DNA (ctDNA) can help predict treatment response and outcomes for people with high‑risk early breast cancer, including inflammatory disease and HER2+ or triple‑negative non‑inflammatory cancers.
-
Web app for reporting side effects during radiation therapy
This project will try a web app that lets people receiving radiation for breast, gynecologic, or urologic cancers report symptoms and quality of life so clinicians can spot problems earlier.
-
Chemotherapy followed by ablative SBRT for locally advanced inoperable pancreatic cancer
This trial will try chemotherapy followed by high-dose focused radiation (SBRT) as the first treatment for adults with locally advanced, inoperable pancreatic cancer.
-
First-line immunotherapy for metastatic melanoma in Slovenia with biomarker identification
This study will try first-line immunotherapy in adults with metastatic melanoma in Slovenia and collect blood, stool, and fluid samples to find markers linked to treatment response.
-
IV lidocaine during colon cancer surgery to lower inflammation and speed recovery
This trial will test if an intravenous lidocaine infusion given around the time of surgery can lower inflammation, reduce pain and opioid use, and help bowel function recover faster in adults having laparoscopic colon cancer surgery.
-
How well patients stick to aromatase inhibitor treatment, with or without abemaciclib, for early HR+/HER2- breast cancer
This study tests whether people with early HR+/HER2- breast cancer stick to aromatase inhibitor treatment more or less when they also take abemaciclib.
-
Identifying genetic markers for radiation therapy response in breast cancer
This study is trying to find genetic clues that can help predict how well breast cancer patients with ductal carcinoma in situ will respond to radiation therapy.
-
Evaluating biomarkers for melanoma immunotherapy response
This study is testing whether certain gut bacteria and blood markers can help predict how well immunotherapy works for people with advanced melanoma.
Quick answers
How many clinical trials run by Institute of Oncology Ljubljana are recruiting right now?
17, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Slovenia. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.